Longevity Health Holdings Inc.
XAGE · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $0 | -$0 | -$0 | $0 |
| % Margin | 87.4% | – | – | – |
| R&D Expenses | $1 | $2 | $2 | $1 |
| G&A Expenses | $4 | $0 | $3 | $1 |
| SG&A Expenses | $4 | $3 | $3 | $1 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | -$0 | $0 |
| Operating Expenses | $5 | $5 | $5 | $2 |
| Operating Income | -$5 | -$5 | -$6 | -$0 |
| % Margin | -9,933.8% | – | – | – |
| Other Income/Exp. Net | -$6 | -$11 | -$4 | $0 |
| Pre-Tax Income | -$11 | -$16 | -$9 | -$0 |
| Tax Expense | -$0 | $0 | $0 | $0 |
| Net Income | -$10 | -$15 | -$9 | -$6 |
| % Margin | -20,605.5% | – | – | – |
| EPS | -0.5 | -0.74 | -0.5 | -0.011 |
| % Growth | 32.4% | -48% | -4,487.2% | – |
| EPS Diluted | -0.5 | -0.74 | -0.5 | -0.011 |
| Weighted Avg Shares Out | 21 | 21 | 20 | 20 |
| Weighted Avg Shares Out Dil | 21 | 21 | 20 | 20 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $2 | $0 |
| Interest Expense | $0 | $1 | $4 | $2 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | -$11 | -$15 | -$5 | -$0 |
| % Margin | -20,870.2% | – | – | – |